ROBERT KRANCE to Cytarabine
This is a "connection" page, showing publications ROBERT KRANCE has written about Cytarabine.
Connection Strength
0.216
-
Guillain-Barr? syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002 Mar; 29(6):515-7.
Score: 0.049
-
Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma. Bone Marrow Transplant. 2022 04; 57(4):579-585.
Score: 0.049
-
Pulmonary insufficiency complicating therapy with high dose cytosine arabinoside in five pediatric patients with relapsed acute myelogenous leukemia. Cancer. 1994 Oct 01; 74(7):1953-8.
Score: 0.029
-
A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group study. Cancer. 1991 Feb 01; 67(3):550-6.
Score: 0.023
-
Biochemical interactions between methotrexate and 1-beta-D-arabinofuranosylcytosine in hematopoietic cells of children: a Pediatric Oncology Group study. Cancer Chemother Pharmacol. 1990; 27(1):60-6.
Score: 0.021
-
A pilot study of continuous infusion Ara-C in combination with rhG-CSF in relapsed childhood acute myeloid leukemia. Leuk Lymphoma. 1997 Aug; 26(5-6):589-93.
Score: 0.009
-
L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins. Leukemia. 1995 Oct; 9(10):1680-4.
Score: 0.008
-
Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol. 1994 Sep; 12(9):1939-45.
Score: 0.007
-
Current strategies for treatment of acute myeloid leukemia at St Jude Children's Research Hospital. Leukemia. 1992; 6 Suppl 2:39-43.
Score: 0.006
-
Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group. Leukemia. 1992; 6 Suppl 2:162-6.
Score: 0.006
-
Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemia. Cancer. 1987 Nov 15; 60(10):2366-71.
Score: 0.005
-
Bone marrow ablation followed by allogeneic marrow grafting during first complete remission of acute nonlymphocytic leukemia. Blood. 1983 Mar; 61(3):439-42.
Score: 0.003